EP3275899
BESTUN MÓTEFNA SEM BINDA EITILFRUMU VIRKJUNARGEN-3 (LAG-3), OG NOTKUN ÞEIRRA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.7.2013EP published:
26.8.2020EP application number:
17177885.5
EP translation filed:
18.11.2020Grant published:
15.12.2020EPO information:
European Patent Register
Max expiry date:
1.7.2033Expiry date:
1.7.2026Next due date:
31.7.2026
Title:
OPTIMIZATION OF ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF
Timeline
Today
2.7.2013EP application
26.8.2020EP Publication
18.11.2020Translation submitted
15.12.2020Registration published
1.7.2026Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
LONBERG, NilsAddress:
Redwood City, CA 94063, US
Name:
SRINIVASAN, MohanAddress:
Redwood City, CA 94063, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201261667058 PDate:
2.7.2012Country:
US
Classification
Categories:
C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 8.6.2021
Expires: 1.7.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 9.6.2022
Expires: 1.7.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.6.2023
Expires: 1.7.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 6.6.2024
Expires: 1.7.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 4.7.2025
Expires: 1.7.2026
Payer: Árnason Faktor ehf.